{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T12:49:31Z","timestamp":1780058971700,"version":"3.54.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Funda\u00e7\u00e3o para a Ci\u00eancia e Tecnologia"},{"name":"COMPETE-FEDER"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.ejpb.2016.11.037","type":"journal-article","created":{"date-parts":[[2016,12,19]],"date-time":"2016-12-19T21:02:06Z","timestamp":1482181326000},"page":"88-96","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["In vivo biodistribution of antihyperglycemic biopolymer-based nanoparticles for the treatment of type 1 and type 2 diabetes"],"prefix":"10.1016","volume":"113","author":[{"given":"Marlene","family":"Lopes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Aniceto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarida","family":"Abrantes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Sim\u00f5es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F\u00e1bio","family":"Branco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Vit\u00f3ria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Filomena","family":"Botelho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Sei\u00e7a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Veiga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ant\u00f3nio","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2016.11.037_b0005","doi-asserted-by":"crossref","unstructured":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group, N. Engl. J. Med. 329 (1993) 977\u201386.","DOI":"10.1056\/NEJM199309303291401"},{"key":"10.1016\/j.ejpb.2016.11.037_b0010","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1055\/s-2007-970423","article-title":"Effectiveness of intensive insulin therapy by multiple daily injections and continuous subcutaneous infusion: a comparison study in type 2 diabetes with conventional insulin regimen failure","volume":"39","author":"Berthe","year":"2007","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.ejpb.2016.11.037_b0015","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1089\/dna.2014.2352","article-title":"Apoptosis of beta cells in diabetes mellitus","volume":"33","author":"Anuradha","year":"2014","journal-title":"DNA Cell Biol."},{"key":"10.1016\/j.ejpb.2016.11.037_b0020","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1021\/acs.chemrestox.5b00171","article-title":"Pathophysiological insights of methylglyoxal induced type-2 diabetes","volume":"28","author":"Dornadula","year":"2015","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.ejpb.2016.11.037_b0025","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1089\/1520915041705929","article-title":"The physiological rationale for oral insulin administration","volume":"6","author":"Arbit","year":"2004","journal-title":"Diabetes Technol. Ther."},{"key":"10.1016\/j.ejpb.2016.11.037_b0030","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0378-5173(92)90353-4","article-title":"In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers","volume":"78","author":"Lehr","year":"1992","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2016.11.037_b0035","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0169-409X(98)00075-1","article-title":"Oral insulin delivery 1","volume":"35","author":"Carino","year":"1999","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2016.11.037_b0040","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/nrd1067","article-title":"Challenges for the oral delivery of macromolecules","volume":"2","author":"Goldberg","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejpb.2016.11.037_b0045","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.drudis.2012.03.019","article-title":"An overview of natural polymers for oral insulin delivery","volume":"17","author":"Sonia","year":"2012","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejpb.2016.11.037_b0050","doi-asserted-by":"crossref","first-page":"e9536","DOI":"10.1371\/journal.pone.0009536","article-title":"Rapid pharmacokinetic and biodistribution studies using cholorotoxin-conjugated iron oxide nanoparticles: a novel non-radioactive method","volume":"5","author":"Lee","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ejpb.2016.11.037_b0055","doi-asserted-by":"crossref","first-page":"20155","DOI":"10.1039\/C5RA26224K","article-title":"Impact of in vitro gastrointestinal passage of biopolymer-based nanoparticles on insulin absorption","volume":"6","author":"Lopes","year":"2016","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejpb.2016.11.037_b0060","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1023\/A:1018967116988","article-title":"Effect of chitosan on the permeability of monolayers of intestinal epithelial cells (Caco-2)","volume":"11","author":"Artursson","year":"1994","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2016.11.037_b0065","doi-asserted-by":"crossref","first-page":"8712","DOI":"10.1016\/j.biomaterials.2011.07.086","article-title":"Effects of chitosan-nanoparticle-mediated tight junction opening on the oral absorption of endotoxins","volume":"32","author":"Sonaje","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejpb.2016.11.037_b0070","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1016\/j.actbio.2009.03.007","article-title":"Colloidal carrier integrating biomaterials for oral insulin delivery: influence of component formulation on physicochemical and biological parameters","volume":"5","author":"Woitiski","year":"2009","journal-title":"Acta Biomater."},{"key":"10.1016\/j.ejpb.2016.11.037_b0075","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ejps.2004.10.010","article-title":"Coating alginate microspheres with a serum albumin-alginate membrane: application to the encapsulation of a peptide","volume":"24","author":"Hurteaux","year":"2005","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2016.11.037_b0080","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ijpharm.2011.04.003","article-title":"Facilitated nanoscale delivery of insulin across intestinal membrane models","volume":"412","author":"Woitiski","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2016.11.037_b0085","doi-asserted-by":"crossref","first-page":"5290","DOI":"10.1002\/jps.21347","article-title":"Nanoparticulate biopolymers deliver insulin orally eliciting pharmacological response","volume":"97","author":"Reis","year":"2008","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2016.11.037_b0090","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1021\/bm0703923","article-title":"Oral bioavailability of insulin contained in polysaccharide nanoparticles","volume":"8","author":"Sarmento","year":"2007","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.ejpb.2016.11.037_b0095","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.ejps.2010.08.009","article-title":"Pharmacological effect of orally delivered insulin facilitated by multilayered stable nanoparticles","volume":"41","author":"Woitiski","year":"2010","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2016.11.037_b0100","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.ejps.2012.01.002","article-title":"Preparation and characterization of insulin-loaded bioadhesive PLGA nanoparticles for oral administration","volume":"45","author":"Zhang","year":"2012","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2016.11.037_b0105","first-page":"23","article-title":"Nanoemulsions coated with alginate\/chitosan as oral insulin delivery systems: preparation, characterization, and hypoglycemic effect in rats","volume":"8","author":"Li","year":"2013","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ejpb.2016.11.037_b0110","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.clim.2015.05.013","article-title":"The gut microbiota and type 1 diabetes","volume":"159","author":"G\u00fclden","year":"2015","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.ejpb.2016.11.037_b0115","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.phrs.2015.02.006","article-title":"Type 1 diabetes and gut microbiota: friend or foe?","volume":"98","author":"Hu","year":"2015","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejpb.2016.11.037_b0120","doi-asserted-by":"crossref","first-page":"e110440","DOI":"10.1371\/journal.pone.0110440","article-title":"Regionally distinct alterations in the composition of the gut microbiota in rats with streptozotocin-induced diabetes","volume":"9","author":"Wirth","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ejpb.2016.11.037_b0125","doi-asserted-by":"crossref","first-page":"e9085","DOI":"10.1371\/journal.pone.0009085","article-title":"Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults","volume":"5","author":"Larsen","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ejpb.2016.11.037_b0130","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.fshw.2013.09.002","article-title":"Microbiota associated with type 2 diabetes and its related complications","volume":"2","author":"Zhang","year":"2013","journal-title":"Food Sci. Human Wellness"},{"key":"10.1016\/j.ejpb.2016.11.037_b0135","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1055\/s-2003-41804","article-title":"Effect of oral oleoyl-estrone on the energy balance of diabetic rats","volume":"35","author":"D\u00edaz-Silva","year":"2003","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.ejpb.2016.11.037_b0140","first-page":"5865","article-title":"Probing insulin bioactivity in oral nanoparticles produced by ultrasonication-assisted emulsification\/internal gelation","volume":"10","author":"Lopes","year":"2015","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ejpb.2016.11.037_b0145","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1166\/jcc.2013.1025","article-title":"Alginate-based micro and nanoparticles coated with chitosan","volume":"1","author":"Lopes","year":"2013","journal-title":"J. Chitin Chitosan Sci."},{"key":"10.1016\/j.ejpb.2016.11.037_b0150","first-page":"553","article-title":"Gastrointestinal uptake and translocation of microparticles in the streptozotocin-diabetic rat","volume":"189","author":"McMinn","year":"1996","journal-title":"J. Anat."},{"key":"10.1016\/j.ejpb.2016.11.037_b0155","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ddtec.2005.05.019","article-title":"Nanoparticle uptake by the oral route: fulfilling its potential?","volume":"2","author":"Florence","year":"2005","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.ejpb.2016.11.037_b0160","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.nano.2014.02.014","article-title":"Intestinal absorption of insulin nanoparticles: contribution of M cells","volume":"10","author":"Lopes","year":"2014","journal-title":"Nanomedicine"},{"key":"10.1016\/j.ejpb.2016.11.037_b0165","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.ejps.2008.11.015","article-title":"Localization and quantification of biodegradable particles in an intestinal cell model: the influence of particle size","volume":"36","author":"Gaumet","year":"2009","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2016.11.037_b0170","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jconrel.2015.12.008","article-title":"Efficient mucus permeation and tight junction opening by dissociable \u201cmucus-inert\u201d agent coated trimethyl chitosan nanoparticles for oral insulin delivery","volume":"222","author":"Liu","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2016.11.037_b0175","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0168-3659(00)00358-8","article-title":"In vitro uptake of polystyrene microspheres: effect of particle size, cell line and cell density","volume":"71","author":"Zauner","year":"2001","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2016.11.037_b0180","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1517\/17425247.5.1.45","article-title":"Nanoparticle strategies for the oral delivery of insulin","volume":"5","author":"Damge","year":"2008","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ejpb.2016.11.037_b0185","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ijpharm.2004.12.025","article-title":"Pharmacological activity of peroral chitosan-insulin nanoparticles in diabetic rats","volume":"293","author":"Ma","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2016.11.037_b0190","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1023\/A:1012029517394","article-title":"The oral absorption of micro- and nanoparticulates: neither exceptional nor unusual","volume":"14","author":"Florence","year":"1997","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2016.11.037_b0195","doi-asserted-by":"crossref","first-page":"E168","DOI":"10.1152\/ajpendo.00501.2007","article-title":"Follow-up of GK rats during prediabetes highlights increased insulin action and fat deposition despite low insulin secretion","volume":"294","author":"Movassat","year":"2008","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.ejpb.2016.11.037_b0200","series-title":"Islets of Langerhans","first-page":"1","article-title":"Islet structure and function in the GK rat","author":"Portha","year":"2014"},{"key":"10.1016\/j.ejpb.2016.11.037_b0205","series-title":"Handbook of Laboratory Animal Science. II","article-title":"Diabetic animal models","author":"Buschard","year":"2003"},{"key":"10.1016\/j.ejpb.2016.11.037_b0210","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1124\/dmd.31.12.1507","article-title":"Modeling of intestinal drug absorption: roles of transporters and metabolic enzymes (for the gillette review series)","volume":"31","author":"Pang","year":"2003","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejpb.2016.11.037_b0215","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jconrel.2016.04.012","article-title":"Dual chitosan\/albumin-coated alginate\/dextran sulfate nanoparticles for enhanced oral delivery of insulin","volume":"232","author":"Lopes","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2016.11.037_b0220","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1248\/bpb.17.327","article-title":"Drug absorption from large intestine: physicochemical factors governing drug absorption","volume":"17","author":"Kimura","year":"1994","journal-title":"Biol. Pharm. Bull."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641116303253?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641116303253?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,5]],"date-time":"2018-09-05T19:50:36Z","timestamp":1536177036000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641116303253"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":44,"alternative-id":["S0939641116303253"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2016.11.037","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vivo biodistribution of antihyperglycemic biopolymer-based nanoparticles for the treatment of type 1 and type 2 diabetes","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2016.11.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}